Practice Agreement
Build an agreement

Collaborative Practice Agreement · PharmD

Florida Written Collaborative Pharmacy Practice Agreement for Pharmacists

Required. The Written Collaborative Pharmacy Practice Agreement is the written instrument Florida law names for a Pharmacist working with a physician. Below: the board that governs it, what it must contain, and the terms it has to carry.

Practice authorityConditional independence
Written agreementAgreement required
What Florida calls itWritten Collaborative Pharmacy Practice Agreement
Governing boardFlorida Board of Pharmacy
Agreement familyCollaborative Practice
Research date2026-08-14 · clauses 2026-09-03

Two narrow, physician-gated pathways rather than general independent prescribing: §465.1865 (chronic conditions — arthritis, asthma, COPD, type 2 diabetes, HIV/AIDS, obesity, others by Board rule) and §465.1895 (2020 'test and treat' — flu, strep, lice, ringworm, athlete's foot, minor uncomplicated infections). Both exclude controlled substances entirely.

Independent practice requires: Certified under §465.1865 (collaborative pharmacy practice, chronic conditions) or §465.1895 (2020 'test and treat,' minor conditions), each requiring an executed written agreement/protocol with a supervising Ch. 458/459 physician.

What a Florida Written Collaborative Pharmacy Practice Agreement must contain

Governed by the Florida Board of Pharmacy. Each numbered item is a statutory requirement the agreement must satisfy.

  1. The Pharmacist may manage specified chronic health conditions for the Physician's patients pursuant to a written collaborative pharmacy practice agreement, as provided by Section 465.1865, Florida Statutes. To do so, the Pharmacist must hold current Collaborative Practice Certification from the Florida Board of Pharmacy, obtained by completing a Board-approved twenty (20) hour certification course, and must maintain at least two hundred fifty thousand dollars ($250,000) of professional liability insurance coverage.

    Source: Section 465.1865, Florida Statutes

  2. The agreement shall name the patient(s) covered, each chronic health condition to be collaboratively managed, and the specific medicinal drug or drugs the Pharmacist may manage, and shall state the circumstances under which the Pharmacist must notify the Physician, the agreement's beginning and ending dates, and that either Party may terminate the agreement in writing. Florida law does not permit the Physician to delegate authority to initiate or prescribe a controlled substance to the Pharmacist under this agreement.

    Source: Section 465.1865, Florida Statutes

  3. The Pharmacist shall submit a copy of the signed agreement to the Florida Board of Pharmacy before the agreement may be implemented, and shall maintain the agreement on file at the practice location.

    Source: Section 465.1865, Florida Statutes

  4. The Written Collaborative Pharmacy Practice Agreement on file also carries 1 scope, 1 education, 1 registration clauses, generated in the document itself.

Statutes and rules cited

  1. Section 465.1865, Florida Statutesstatute

    Collaborative pharmacy practice for chronic health conditions -- certification, required agreement contents, Board filing, and professional liability insurance requirements.

  2. Section 458.347, Florida Statutesstatute

    Caps the number of Physician Assistants a supervising physician may supervise at one time (raised from four to ten by 2021 c. 2021-118, Laws of Fla.).

Terms it has to carry

Ratio, proximity, chart review, meeting and prescribing terms the agreement has to carry, from the state's supervision rules.

Proximity

Not codified — left to the agreement

Supervision ratio

Not codified — no cap on file

Chart review

Not codified — left to the agreement

Meeting cadence

As needed

§465.1895's written protocol must specify a 'physician review process and schedule' — frequency is determined by the individual protocol, not fixed by statute. §465.1865's collaborative practice agreement has no analogous review-schedule mandate found.

Prescriptive authority

Separate prescribing terms required · no controlled-substance authority

Both §465.1865 and §465.1895 explicitly exclude controlled substances (referencing §893.03/21 U.S.C. §812) from the pharmacist's delegated authority — no schedule of controlled substance may be initiated or prescribed under either pathway.

Written agreement

Required

True for both pathways — an executed written agreement (§465.1865) or protocol (§465.1895) is mandatory to invoke either one; there is no branch where a pharmacist prescribes under this framework without one.

Practice ownership (corporate practice of medicine)

Non-licensee ownership permitted — Non-pharmacists may own a Florida pharmacy (§465.015(4)(b), §465.022) — no ownership restriction by license. Clinical control instead runs through a designated 'prescription department manager' (community pharmacies, §465.018) or 'consultant pharmacist' (institutional pharmacies, §465.019) — Florida's statutory terms for the role commonly called 'pharmacist in charge' (PIC) in industry usage.

Materially more permissive than the physician/APRN framework above, same pattern as other states' pharmacist entries in this dataset.

Legal sources for these rules (4)
How the relationship works day to day
Who has to be where, how often you meet, and what the physician costs: Pharmacist in Florida on collaborativeagreement.com.

About Florida's rules

Florida's 2020 autonomous-practice law (§464.0123, ≥3,000 supervised hours + coursework) creates a real independence pathway for NP and CNM — but excludes PMHNP, CRNA, and CNS entirely; CRNA autonomy bills have died three sessions running (2024-2026). Florida has no corporate-practice-of-medicine doctrine (secondary-source consensus) — entity ownership instead turns on the Health Care Clinic Act's §400.9905 exemption mechanics. Supervision ratio/chart-review/meeting-cadence are largely uncodified; PA's 10-supervisee cap is the exception.

Other clinicians in Florida: see the state overview.